Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.50 (1.03%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £60.22m
FEN Live PriceLast checked at - London Stock Exchange

Intraday Frenkel Topping Share Chart

Form 8.5 (EPT/NON-RI)

25 Sep 2025 08:50

RNS Number : 8060A
Cavendish Securities PLC
25 September 2025
 

FORM 8.5 (EPT/NON-RI)

 

 

 

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Cavendish Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

FRENKEL TOPPING GROUP PLC

 

 

(c) Name of the party to the offer with which exempt principal trader is connected:

FRENKEL TOPPING GROUP PLC

 

 

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

24/09/2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORD 0.5P

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

122363

 

0.0956%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

122363

 

0.0956%

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ORD 0.5P

ORD 0.5P

 

Purchases

Sales

3000

1000

46

46.55

 

 

46

46.55

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

25/09/2025

Contact name:

Umika Patel

Telephone number:

+44 (0) 20 7220 0529

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOUVSBRVBUKURR
Date   Source Headline
23rd Aug 201911:56 amRNSHolding(s) in Company
15th Jul 20192:14 pmRNSFrenkel Topping comment re: Ogden rate
3rd Jun 20197:00 amRNSAppointment of Tatton Asset Management to Ascencia
30th May 201912:35 pmRNSResult of AGM
30th May 20197:00 amRNSAGM Statement
9th May 20197:00 amRNSFrenkel Topping Deputy Day
10th Apr 20197:00 amRNSFinal Results
5th Mar 20196:04 pmRNSTransaction in own shares and TVR
1st Feb 20194:12 pmRNSTransaction in Own Shares
31st Jan 20197:00 amRNSPre Close Trading Update
13th Dec 20187:00 amRNSTransaction in own shares and TVR
4th Dec 20189:27 amRNSTransaction in Own Shares and TVR
22nd Nov 20184:47 pmRNSDirector/PDMR Shareholding
22nd Nov 20187:00 amRNSShare Buy Back Programme
14th Nov 201810:19 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSTrading Update
5th Sep 20187:00 amRNSInterim Results
27th Jul 20182:27 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSBusiness and trading update
19th Jun 20188:00 amRNSAppointment of Joint Broker
19th Jun 20187:00 amRNSBoard Changes
11th Apr 20182:00 pmRNSDirector/PDMR Shareholding
9th Apr 20188:25 amRNSFinal Results
20th Mar 20187:00 amRNSNotice of Results
7th Feb 20187:00 amRNSAppointment of Portfolio Research Partner
20th Dec 20177:00 amRNSStrategic Update
18th Dec 20177:00 amRNSTransaction in Own Shares
15th Dec 20177:00 amRNSShare Buyback, Director Dealing & Resignation
1st Dec 20177:00 amRNSEmployee Benefit Trust Purchase
14th Nov 20177:00 amRNSTrading Update
2nd Oct 20177:00 amRNSDirectorate Appointment and Board Change
28th Sep 201711:00 amRNSHolding(s) in Company
22nd Sep 20172:16 pmRNSHolding(s) in Company
21st Sep 20171:11 pmRNSHolding(s) in Company
20th Sep 20175:21 pmRNSHolding(s) in Company
20th Sep 20174:46 pmRNSHolding(s) in Company
20th Sep 20174:44 pmRNSHolding(s) in Company
20th Sep 20174:42 pmRNSHolding(s) in Company
18th Sep 20179:26 amRNSPCA Dealing & Concert Party Update
6th Sep 20177:00 amRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSDirectorate Change
1st Aug 20178:45 amRNSDirector Dealing
18th Jul 201710:17 amRNSDirector/PDMR Shareholding
13th Jul 20178:19 amRNSHolding(s) in Company
6th Jul 201710:01 amRNSHolding(s) in Company
5th Jul 20171:53 pmRNSExercise of Options and Concert Party Update
5th Jul 20177:00 amRNSHalf-year Report
3rd Jul 20177:00 amRNSRepayment of £3m SPV Loan
27th Jun 20175:31 pmRNSForm 8.3 - Brown Shipley & Co Ltd
27th Jun 20175:30 pmRNSForm 8.3 - Brown Shipley & Co Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.